MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Henry Schein Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

68.99 1.05

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

67.91

Max

69.46

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3M

96M

Pardavimai

17M

3.2B

P/E

Sektoriaus vid.

22.456

63.778

Pelnas, tenkantis vienai akcijai

1.19

Pelno marža

3.008

Darbuotojai

25,000

EBITDA

1M

237M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+16.69% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.8B

8.5B

Ankstesnė atidarymo kaina

67.94

Ankstesnė uždarymo kaina

68.99

Naujienos nuotaikos

By Acuity

44%

56%

150 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Henry Schein Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-01-29 13:28; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

2025-01-29 14:04; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

KKR Builds Stake in Medical-Supply Company -- 2nd Update

2025-01-29 12:54; UTC

Įsigijimai, susijungimai, perėmimai

KKR Builds Stake in Medical-Supply Company -- Update

2025-01-29 12:07; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

2025-01-29 12:07; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

2025-01-29 12:06; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

2025-01-29 12:06; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 4Q Rev $3.2B >HSIC

2025-01-29 12:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

2025-01-29 12:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

2025-01-29 12:02; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Names Robert Hombach an Independent Director >HSIC

2025-01-29 12:02; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

2025-01-29 12:02; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

2025-01-29 12:01; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

2025-01-29 12:00; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

2025-01-29 12:00; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

2025-01-29 10:30; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

2025-01-29 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Henry Schein Has Already Been an Activist Target -- WSJ

2025-01-29 10:30; UTC

Įsigijimai, susijungimai, perėmimai

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

2025-01-29 10:30; UTC

Įsigijimai, susijungimai, perėmimai

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Akcijų palyginimas

Kainos pokytis

Henry Schein Inc Prognozė

Kainos tikslas

By TipRanks

16.69% į viršų

12 mėnesių prognozė

Vidutinis 79.92 USD  16.69%

Aukščiausias 90 USD

Žemiausias 55 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Henry Schein Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

13 ratings

4

Pirkti

8

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

68.765 / 70.7Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

150 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.